Citigroup »

Context Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $88k 45k 1.96

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Citigroup

Top funds holding Context Therapeutics

Deep Track Capital
Nextech Invest
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Blue Owl Capital Holdings
Vanguard Group
Blackstone Group
Nantahala Capital Management
Franklin Resources
Alyeska Investment Group
Woodline Partners
Sio Capital Management
Affinity Asset Advisors
BlackRock
BlackRock

View all funds holding Context Therapeutics